BR112014009265A2 - micelas de proteína de soro do leite contra atrofia muscular e sarcopenia - Google Patents
micelas de proteína de soro do leite contra atrofia muscular e sarcopeniaInfo
- Publication number
- BR112014009265A2 BR112014009265A2 BR112014009265A BR112014009265A BR112014009265A2 BR 112014009265 A2 BR112014009265 A2 BR 112014009265A2 BR 112014009265 A BR112014009265 A BR 112014009265A BR 112014009265 A BR112014009265 A BR 112014009265A BR 112014009265 A2 BR112014009265 A2 BR 112014009265A2
- Authority
- BR
- Brazil
- Prior art keywords
- whey protein
- protein micelles
- sarcopenia
- muscle atrophy
- against muscle
- Prior art date
Links
- 108010046377 Whey Proteins Proteins 0.000 title abstract 6
- 102000007544 Whey Proteins Human genes 0.000 title abstract 6
- 239000000693 micelle Substances 0.000 title abstract 6
- 235000021119 whey protein Nutrition 0.000 title abstract 6
- 206010028289 Muscle atrophy Diseases 0.000 title abstract 2
- 230000020763 muscle atrophy Effects 0.000 title abstract 2
- 201000000585 muscular atrophy Diseases 0.000 title abstract 2
- 208000001076 sarcopenia Diseases 0.000 title abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 235000012054 meals Nutrition 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C2210/00—Physical treatment of dairy products
- A23C2210/40—Microencapsulation; Encapsulation of particles
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pediatric Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Marine Sciences & Fisheries (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Obesity (AREA)
Abstract
abstract the present invention relates to whey protein micelles for use in the treatment and/or prevention of a condition linked to a reduced concentration of plasma amino acids in a patient. a further aspect of the invention is a meal replacement comprising whey protein micelles. tradução do resumo resumo patente de invenção: "micelas de proteína de soro do leite contra atrofia muscular e sarcopenia". a presente invenção refere-se a micelas de proteína de soro do leite para uso no tratamento e/ou prevenção de uma afecção ligada a uma concentração reduzida de aminoácidos de plasma em um paciente. um aspecto adicional da invenção é uma substituto de refeição que compreende micelas de proteína de soro do leite.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11186143.1A EP2583563A1 (en) | 2011-10-21 | 2011-10-21 | Whey protein micelles against muscle atrophy and sarcopenia |
PCT/EP2012/070714 WO2013057230A1 (en) | 2011-10-21 | 2012-10-19 | Whey protein micelles against muscle atrophy and sarcopenia |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112014009265A2 true BR112014009265A2 (pt) | 2017-06-13 |
BR112014009265A8 BR112014009265A8 (pt) | 2017-06-20 |
Family
ID=47040743
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014009265A BR112014009265A8 (pt) | 2011-10-21 | 2012-10-19 | micelas de proteína de soro do leite contra atrofia muscular e sarcopenia |
Country Status (9)
Country | Link |
---|---|
US (2) | US20140249078A1 (pt) |
EP (3) | EP2583563A1 (pt) |
JP (1) | JP2014534203A (pt) |
CN (1) | CN103945711B (pt) |
AU (1) | AU2012324884B2 (pt) |
BR (1) | BR112014009265A8 (pt) |
CA (1) | CA2853167C (pt) |
ES (2) | ES2683176T3 (pt) |
WO (1) | WO2013057230A1 (pt) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180343910A1 (en) * | 2014-11-19 | 2018-12-06 | Nestec S.A. | Complexes of whey protein micelles and pectin and body muscle protein synthesis |
CN108347987A (zh) * | 2015-11-17 | 2018-07-31 | 雀巢产品技术援助有限公司 | 将多酚用于肌肉骨骼健康的组合物和方法 |
US10744100B2 (en) | 2015-11-17 | 2020-08-18 | Societe Des Produits Nestle S.A. | Compositions and methods using a polyphenol for musculoskeletal health |
EP3851114A1 (en) * | 2015-11-20 | 2021-07-21 | Société des Produits Nestlé S.A. | Composition comprising micellar whey protein, vitamin d and clacium to improve or maintain muscle |
CA3027112A1 (en) | 2016-06-10 | 2017-12-14 | Nestec S.A. | Heat sterilized high protein enteral compositions with whey protein which comprises whey protein micelles and a source of casein |
WO2017211856A1 (en) | 2016-06-10 | 2017-12-14 | Nestec S.A. | Heat sterilized high protein enteral compositions with whey protein which comprises whey protein micelles and a source of casein |
JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
HRP20231746T1 (hr) | 2017-02-17 | 2024-04-26 | Arla Foods Amba | Visokoproteinski, acidificiran, tekući mliječni proizvod koji ima smanjenu viskoznost, postupak njegove proizvodnje i odgovarajući sastojci |
WO2018164251A1 (ja) * | 2017-03-10 | 2018-09-13 | 株式会社明治 | 体力向上用組成物 |
TWI761487B (zh) * | 2017-04-06 | 2022-04-21 | 日商明治股份有限公司 | 用於促進血中胺基酸濃度上升之發酵乳 |
JP7266581B2 (ja) | 2017-08-14 | 2023-04-28 | アクセラ・ヘルス・インコーポレイテッド | 肝疾患の治療のためのアミノ酸組成物 |
JP2021503878A (ja) * | 2017-11-21 | 2021-02-15 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | 筋肉の質及び/又は筋量のためのオレウロペイン又はクルクミンを使用する組成物及び方法 |
US10596136B2 (en) | 2018-06-20 | 2020-03-24 | Axcella Health Inc. | Compositions and methods for the treatment of fat infiltration in muscle |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2683492B2 (ja) * | 1993-09-07 | 1997-11-26 | 雪印乳業株式会社 | ミセル状ホエー蛋白質、その溶液、その粉末およびミセル状ホエー蛋白質の製造法 |
CN1273030C (zh) | 1998-10-16 | 2006-09-06 | 雀巢制品公司 | 缓慢消化的蛋白质及其用途 |
DE19964370B4 (de) | 1999-02-16 | 2006-05-11 | Huss, Manfred | Herstellung eines geschäumten Molkenproteinprodukts |
MY153295A (en) * | 2004-09-29 | 2015-01-29 | Nestec Sa | Nanoparticulated whey proteins |
ES2411029T3 (es) * | 2005-01-18 | 2013-07-04 | Desarrollos Especiales De Sistemas De Anclaje, S.A. | Grapa para atar tallos o ramas de plantas a una cuerda, palo u otro elemento guía |
ES2373400T3 (es) | 2006-03-27 | 2012-02-03 | Nestec S.A. | Micelas de proteína láctea. |
ATE506861T1 (de) * | 2006-03-27 | 2011-05-15 | Nestec Sa | Molkenproteinträger zur abgabe von aktivsubstanzen |
WO2008086538A1 (en) | 2007-01-14 | 2008-07-17 | Glanbia Plc | Branched chain amino acid chelate |
CA2805888C (en) * | 2008-10-17 | 2016-08-16 | Nestec S.A. | Whey protein compostions, methods and uses |
SG177664A1 (en) * | 2009-07-20 | 2012-02-28 | Nestec Sa | Methods of attenuating the loss of functional status |
WO2011078654A1 (en) * | 2009-12-24 | 2011-06-30 | N.V. Nutricia | Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis |
WO2011112695A1 (en) * | 2010-03-12 | 2011-09-15 | Nestec S.A. | Compositions for masking the flavor of nutrients and methods for making same |
AU2012244750A1 (en) * | 2011-04-18 | 2013-10-17 | Nestec S.A. | Nutritional compositions having alpha-HICA and eicosapentaenoic acid |
PL2583566T3 (pl) * | 2011-10-21 | 2016-01-29 | Nestec Sa | Micele serwatkowego białka do zwiększania masy mięśni i sprawności |
EP2583565A1 (en) * | 2011-10-21 | 2013-04-24 | Nestec S.A. | Use of whey protein micelles for enhancing energy expenditure and satiety |
EP2583564A1 (en) * | 2011-10-21 | 2013-04-24 | Nestec S.A. | Use of whey protein micelles for improving insulin profile in diabetic patients |
US10251913B2 (en) * | 2014-11-19 | 2019-04-09 | Nestec S.A. | Use of whey protein micelles and polysaccharides for improving insulin profile |
US20180343910A1 (en) * | 2014-11-19 | 2018-12-06 | Nestec S.A. | Complexes of whey protein micelles and pectin and body muscle protein synthesis |
-
2011
- 2011-10-21 EP EP11186143.1A patent/EP2583563A1/en not_active Withdrawn
-
2012
- 2012-10-19 ES ES12773336.8T patent/ES2683176T3/es active Active
- 2012-10-19 BR BR112014009265A patent/BR112014009265A8/pt not_active Application Discontinuation
- 2012-10-19 EP EP12773336.8A patent/EP2768322B1/en not_active Revoked
- 2012-10-19 WO PCT/EP2012/070714 patent/WO2013057230A1/en active Application Filing
- 2012-10-19 EP EP18174303.0A patent/EP3398454B1/en active Active
- 2012-10-19 CN CN201280051739.4A patent/CN103945711B/zh active Active
- 2012-10-19 ES ES18174303T patent/ES2894296T3/es active Active
- 2012-10-19 AU AU2012324884A patent/AU2012324884B2/en active Active
- 2012-10-19 CA CA2853167A patent/CA2853167C/en active Active
- 2012-10-19 JP JP2014536244A patent/JP2014534203A/ja active Pending
- 2012-10-19 US US14/353,177 patent/US20140249078A1/en not_active Abandoned
-
2021
- 2021-11-16 US US17/527,408 patent/US20220072096A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP2768322B1 (en) | 2018-05-30 |
ES2683176T3 (es) | 2018-09-25 |
EP2583563A1 (en) | 2013-04-24 |
EP3398454B1 (en) | 2021-07-21 |
AU2012324884A1 (en) | 2014-05-01 |
CA2853167C (en) | 2020-06-02 |
ES2894296T3 (es) | 2022-02-14 |
EP2768322A1 (en) | 2014-08-27 |
BR112014009265A8 (pt) | 2017-06-20 |
AU2012324884B2 (en) | 2016-08-11 |
US20140249078A1 (en) | 2014-09-04 |
CA2853167A1 (en) | 2013-04-25 |
CN103945711A (zh) | 2014-07-23 |
JP2014534203A (ja) | 2014-12-18 |
US20220072096A1 (en) | 2022-03-10 |
WO2013057230A1 (en) | 2013-04-25 |
EP3398454A1 (en) | 2018-11-07 |
CN103945711B (zh) | 2016-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014009265A2 (pt) | micelas de proteína de soro do leite contra atrofia muscular e sarcopenia | |
AU2018201997B2 (en) | Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions | |
BR112013026706A2 (pt) | composições nutricionais compreendendo ácido alfa-hidroxi-isocaproico | |
BR112012018256A8 (pt) | método de tratamento de doença de parkinson | |
BR112014009418A2 (pt) | macrociclos peptidomiméticos | |
NZ757815A (en) | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity | |
BR112014008036A2 (pt) | tratamento de rinite | |
BR112014010275A2 (pt) | formulações para tratamento de diabetes | |
IN2014KN02830A (pt) | ||
BR112014009225A8 (pt) | uso de micelas de proteína de soro de leite para crianças pequenas em risco de obesidade ou diabetes | |
BR112013020586A2 (pt) | Uso de células derivadas de tecido do cordão umbilical | |
BR112012008238A2 (pt) | métodos para prevenção ou tratamento de sarcopenia e atrofia muscular em animais. | |
BR112013031652A2 (pt) | métodos de tratamento para doenças retinais | |
BR112012006010A2 (pt) | composto de glicina | |
BR112013033008A8 (pt) | composição farmacêutica líquida compreendendo nitisinona | |
CO6592101A2 (es) | Metodos para tratar ulceras de pie de diabetico | |
BR112012015202A2 (pt) | "iota - e/ou kappa-carrgenado junto com um inibidor da neuraminidase, método para o tratamento profilático ou terapêutico de um sintoma, condição ou doença, composição farmacêutica,e, kit de partes". | |
BR112014030813A2 (pt) | tratamento de efeitos colaterais de desordens motoras e de movimento associadas com tratamentos de doenças parkinson | |
BR112018000242A2 (pt) | composições nutricionais contendo fosfatidiletanolamina, esfingomielina e ácido doco-saexaenóico | |
BR102013003570A8 (pt) | Composições de plasma rico em plaquetas | |
BR112014019399A2 (pt) | métodos de tratamento da fibrose | |
WO2009140269A3 (en) | Recombinant human cc10 and compositions thereof for use in the treatment of nasal rhinitis | |
BR112015013708A2 (pt) | polipeptídeo compreendendo uma proteína igf-1 humana, polinucleotídeo, composição farmacêutica e uso | |
MX2013006094A (es) | Metodo para inhibir patogenos usando composicion nutricional. | |
WO2014071168A3 (en) | Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Ipc: A61K 38/17 (2006.01), A23L 33/19 (2016.01), A23L 3 |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI. |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: SOCIETE DES PRODUITS NESTLE S.A. (CH) |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |
|
B350 | Update of information on the portal [chapter 15.35 patent gazette] |